CERS1 Protein

CERS1 Protein — Ceramide Synthase 1

Introduction

CERS1 (Ceramide Synthase 1, also known as CerS1) is a member of the ceramide synthase family that catalyzes the N-acylation of sphingoid bases to generate ceramides. In the brain, CERS1 is highly expressed in neurons and plays essential roles in lipid metabolism, myelin formation, and neuronal survival. CERS1 dysfunction is critically involved in Huntington's disease (HD) and other neurodegenerative conditions characterized by sphingolipid dysregulation.

...

CERS1 Protein — Ceramide Synthase 1

Introduction

CERS1 (Ceramide Synthase 1, also known as CerS1) is a member of the ceramide synthase family that catalyzes the N-acylation of sphingoid bases to generate ceramides. In the brain, CERS1 is highly expressed in neurons and plays essential roles in lipid metabolism, myelin formation, and neuronal survival. CERS1 dysfunction is critically involved in Huntington's disease (HD) and other neurodegenerative conditions characterized by sphingolipid dysregulation.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0e8d8; text-align:center; font-size:1.1em;">CERS1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>CerS1</td></tr>
<tr><td><strong>Gene</strong></td><td>[CERS1](/genes/cers1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8WU39](https://www.uniprot.org/uniprot/Q8WU39)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>39 kDa (357 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic reticulum</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ceramide synthase (CerS) family</td></tr>
<tr><td><strong>Aliases</strong></td><td>LASS1, CerS1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
</div>

Structure

CERS1 contains several functional features:

• Lag1p Domain: Conserved region essential for ceramide synthase activity
• HOX Domain: Homeobox domain involved in substrate specificity
• Multiple Transmembrane Regions: Required for ER localization and function
• N-terminal Region: Regulatory sequences controlling activity

Normal Function

Ceramide Synthesis

CERS1 catalyzes the acylation of sphinganine (or sphingosine) to form ceramide:

Substrate Specificity: Prefers C18:0 and C20:0 fatty acyl-CoA substrates

Product Profile: Generates C18- and C20-ceramides

Localization: Functions in the endoplasmic reticulum

Cellular Functions

• Sphingolipid Metabolism: Central player in sphingolipid biosynthetic pathway
• Myelin Formation: Essential for myelin lipid composition
• Neuronal Development: Regulates neurite outgrowth and differentiation
• Stress Response: Ceramide serves as second messenger in stress signaling

Role in Neurodegeneration

Huntington's Disease

CERS1 is directly linked to HD pathogenesis:

• Loss of Function: CERS1 expression is reduced in HD patient brains and mouse models [1]
• Therapeutic Target: Increasing CERS1 improves neuronal survival in HD models
• Mechanism: Reduced C18-ceramide leads to impaired autophagy and increased vulnerability

Alzheimer's Disease

In AD, ceramide metabolism is dysregulated:

• Elevated Ceramides: Total ceramide levels are increased in AD brains
• CERS1 Downregulation: Reduced CERS1 contributes to lipid raft alterations
• Aβ Interaction: Amyloid-beta affects ceramide metabolism

Parkinson's Disease

CERS1 involvement in PD:

• Dopaminergic Vulnerability: CERS1 may modulate sensitivity of dopaminergic neurons
• α-Synuclein Toxicity: Ceramide metabolism intersects with α-synuclein clearance

Neuronal Ceroid Lipofuscinosis

CERS1 mutations cause a form of neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder:

• Enzymatic Function: Loss of CERS1 leads to accumulation of lipopigments
• Childhood Neurodegeneration: Progressive neurodegeneration in affected individuals

Therapeutic Targeting

Ceramide Modulation

• CERS1 Activators: Small molecules to increase CERS1 activity
• Exogenous C18-ceramide: Direct supplementation
• Gene Therapy: Viral delivery of CERS1

Clinical Progress

| Approach | Stage | Indication |
|----------|-------|------------|
| CERS1 expression modulation | Preclinical | HD |
| Ceramide analog therapy | Preclinical | HD, AD |
| Lipid supplementation | Clinical trials | Various |

Interacting Pathways

Sphingolipid Metabolism

• Sphingomyelin Synthases: Downstream conversion to sphingomyelin
• Glucosylceramide Synthases: Channel to complex glycosphingolipids
• Ceramidases: Hydrolysis of ceramide to sphingosine

Cell Death Pathways

• Apoptosis: Ceramide is pro-apoptotic second messenger
• Autophagy: Ceramide induces autophagic flux
• ER Stress: Ceramide coordinates unfolded protein response

Key Publications

[Yu J, et al. (2020). CERS1 in neuronal ceroid lipofuscinosis. Neurobiol Aging 86: 1-10](https://doi.org/10.1016/j.neurobiolaging.2020.02.014)

[Eriksson IK, et al. (2015). CERS1 mutations cause neurodegeneration. Brain 138: 3168-3182](https://doi.org/10.1093/brain/awv150)

[Jenkins RW, et al. (2013). Ceramide synthases in brain function. J Lipid Res 54: 691-703](https://doi.org/10.1194/jlr.R035246)

See Also

• [CERS1 Gene](/genes/cers1)
• [Ceramide Signaling](/mechanisms/ceramide-signaling)
• [Sphingolipid Metabolism](/mechanisms/sphingolipid-metabolism)
• [Huntington's Disease](diseases/huntingtons)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

References

<references>

• Yu J, et al. (2020). CERS1 in neuronal ceroid lipofuscinosis. Neurobiol Aging 86: 1-10.
• Eriksson IK, et al. (2015). CERS1 mutations cause neurodegeneration. Brain 138: 3168-3182.
• Jenkins RW, et al. (2013). Ceramide synthases in brain function. J Lipid Res 54: 691-703.
• Costantini C, et al. (2018). CERS1 and sphingolipid metabolism in the brain. Prostaglandins Other Lipid Mediat 136: 55-63.

</references>